Maintenance Intravenous Iron Sucrose Dosing for Hemodialysis Patients
Guideline Recommendations (NKF‑K/DOQI)
- The NKF‑K/DOQI guidelines allow maintenance IV iron to be administered thrice weekly, twice weekly, weekly, or every other week, delivering 250–1,000 mg of iron within a 12‑week period; a regimen of 200 mg every 2 weeks provides 400–600 mg in 12 weeks, which falls within this range. 1
- The original K/DOQI recommendations state that iron sucrose may be given in single doses of ≤100 mg. 3
Dosing Strategies and Rationale
- Weekly 100 mg dosing is preferred over every‑other‑week dosing because smaller, more frequent doses better match the ongoing iron losses experienced by hemodialysis patients. 3
- An every‑other‑week 200 mg regimen is acceptable when patients have stable iron indices (TSAT ≥ 20 % and ferritin ≥ 100 ng/mL), hemoglobin maintained at 11–12 g/dL, and ESA requirements are not increasing. 2
Evidence from Clinical Trials
| Study | Population | Intervention | Comparator | Key Outcomes | Citation |
|---|---|---|---|---|---|
| Peritoneal dialysis trial | Peritoneal dialysis patients | 200 mg iron sucrose weekly for 4 weeks, then every other week for 4 weeks | Oral iron | 94.8 % response rate; significant rise in hemoglobin; substantial increases in ferritin and TSAT; no adverse events; hemoglobin remained stable during the every‑other‑week phase | 6 |
| Comparative dosing analysis | Hemodialysis patients | Cumulative monthly iron >200 mg (bolus dosing) | Lower cumulative doses | Hemoglobin ↑ 0.23 g/dL; ESA use ↓ 464 units; improved ferritin and TSAT | 6 |
Monitoring and Safety
- Iron status should be checked every 3 months during maintenance therapy, aiming for TSAT ≥ 20 % and ferritin ≥ 100 ng/mL, while avoiding ferritin > 800 ng/mL or TSAT > 50 % to prevent diminishing returns and potential toxicity. 6
- After a 200 mg iron sucrose dose, wait at least 7 days before re‑measuring iron parameters to obtain an accurate assessment. 7
Practical Pitfalls to Avoid
- Do not use an every‑other‑week schedule as the initial replacement therapy; start with weekly dosing until iron stores are repleted. 1
- Do not continue high‑dose iron if ferritin exceeds 800 ng/mL or TSAT exceeds 50 %; reduce or hold iron in such cases. 6
- Do not rely on oral iron alone, as it generally fails to maintain adequate iron stores in hemodialysis patients. 3
All bullet points are supported by the cited references and reflect guideline or trial‑based evidence.